Introduction: Sexual dysfunction is a common side effect of antipsychotic treatment and may contribute to non-adherence. In the QUALIFY study (NCT01795547) the effectiveness of aripiprazo...
Abstract: Background
Bipolar I disorder (BP-I) patients often have numerous unmet needs. There exists a paucity of evidence on the goals of patients diagnosed with BP-I that could help gu...
Abstract: Background: Aripiprazole 2-month ready-to-use 960 mg (2MRTU 960) is a new formulation of aripiprazole monohydrate intended for the treatment of schizophrenia or maintenance mono...